Meyka Pro banner
Electromed, Inc.

Electromed, Inc. (AMEX: ELMD) Stock Competitors & Peer Comparison

See ELMD's competitors and their performance on the AMEX and across the wider stock market.

ELMDAMEX
HealthcareMedical - Devices
$42.54
$0.06(0.14%)
U.S. Market opens in 3h 8m

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more for ELMD and its AMEX peers.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ELMD$42.54+0.14%351.1M36.24$1.17N/A
ABT$111.27+0.32%192.6B21.36$5.21+2.23%
BSX-PA$122.18+2.37%175.4B230.53$0.53N/A
SYK$341.09-1.76%130.8B25.47$13.39+1.02%
MDT$90.58-0.20%116B16.38$5.53+3.14%
BSX$51.69+0.53%76.9B16.68$3.10N/A
EW$92.56-0.53%53.3B34.29$2.70N/A
DXCM$91.48+0.75%34.5B39.26$2.33N/A
RMD$226.74+0.33%32.9B21.06$10.77+1.05%
PHG$27.38+2.16%26.8B15.64$1.75+3.62%
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

Abbott Laboratories (NYSE: ABT)

ELMD vs ABT Comparison August 2026

Electromed, Inc. (AMEX: ELMD) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELMD stands at 351.1M. In comparison, ABT has a market cap of 192.6B. Regarding current trading prices, ELMD is priced at $42.54 on the AMEX, while ABT trades at $111.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELMD currently has a P/E ratio of 36.24, whereas ABT's P/E ratio is 21.36. In terms of profitability, ELMD's ROE is +0.22%, compared to ABT's ROE of +0.11%. Regarding short-term risk, ELMD is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for ELMD.Check ABT's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions